Wiley Periodicals, Inc

SHERPA: Unknown

People

  1. Antonescu
    Antonescu
  2. Wolden
    Wolden
  3. Cheung
    Cheung
  4. Modak
    Modak
  5. Dunkel
    Dunkel
  6. Kushner
    Kushner
  7. Kramer
    Kramer
  8. Wexler
    Wexler
  9. La Quaglia
    La Quaglia
  10. Sklar
    Sklar

Groups

  1. Pediatrics, Department of (430)
  2. GSK Faculty (252)
  3. Tow Center for Developmental Oncology (TCDO) (237)
  4. Center for Hematologic Malignancies (190)
  5. Survivorship Research (187)
  6. Department of Pathology and Laboratory Medicine (175)
  7. Pediatric Leukemia (150)
  8. Surgery (133)
  9. Neuroblastoma Service (119)
  10. Neuro-Oncology Service (114)
Search Within
Formats
  1. Journal Article (480)
  2. Meeting Abstract (247)
  3. Review (24)
  4. Correspondence (11)
  5. Guidelines (9)
  6. Editorial (5)
  7. Conference Paper (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Pediatrics, Department of (430)
  2. GSK Faculty (252)
  3. Tow Center for Developmental Oncology (TCDO) (237)
  4. Center for Hematologic Malignancies (190)
  5. Survivorship Research (187)
  6. Department of Pathology and Laboratory Medicine (175)

More Groups

People
  1. Cristina Antonescu (104)
  2. Suzanne Wolden (74)
  3. Nai-Kong Cheung (70)
  4. Shakeel Modak (68)
  5. Brian Kushner (65)
  6. Ira Dunkel (65)

More People

Years
  1. 2025 (17)
  2. 2024 (29)
  3. 2023 (60)
  4. 2022 (57)
  5. 2021 (57)
  6. 2020 (56)

More Years

Publications
  1. Pediatric Blood and Cancer (544)
  2. Genes Chromosomes and Cancer (184)
  3. Developmental Dynamics (24)
  4. Wiley Interdisciplinary Reviews: Developmental Biology (7)
  5. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (4)
  6. Echocardiography (3)

More Publications

Results (779)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ALK inhibitors for treatment of adult-onset neuroblastoma
    Meeting Abstract

    Stiefel, J.; Kushner, B.; Roberts, S.; Basu, E.; Modak, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Skeletal muscle metastases in neuroblastoma: An ostensible "forme fruste" of stage MS disease
    Meeting Abstract

    Fong, C.; Kushner, B.; Di Giannatale, A.; Roberts, S.; Basu, E.; Price, A.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
    Meeting Abstract

    Shahid, S.; Kushner, B.; Modak, S.; Basu, E.; Rubin, E.; Gundem, G.; Papaemmanuil, E.; Roberts, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Real world indications and use of chimeric antigen receptor T cell therapy in pediatric patients with relapsed or high-risk leukemia
    Meeting Abstract

    Barsan, V.; Baggott, C.; Prabhu, S.; Pacenta, H.; Philips, C.; Rossoff, J.; Stefanski, H.; Talano, J. A.; Moskop, A.; Margossian, S.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Histologic subtype predicts disparate outcomes in pediatric hepatocellular carcinoma - A pediatric surgical oncology research collaborative study
    Meeting Abstract

    Short, S.; Kastenberg, Z.; Bondoc, A.; Dasgupta, R.; Tiao, G.; Watters, E.; Heaton, T.; Lotakis, D.; Laquaglia, M.; Murphy, A.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia
    Meeting Abstract

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • A phase 1/2, open-label study of repotrectinib in pediatric and young adult patients with advanced or metastatic malignancies harboring ALK, ROS1, or NTRK1-3 alterations
    Meeting Abstract

    Dubois, S.; O'Donohue, T.; Kang, H. J.; Federman, N.; Watt, T.; Cluster, A.; Zimmerman, Z.; Trone, D.; Mascarenhas, L.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Naxitamab treatment of refractory/relapsed high-risk neuroblastoma (R/R HR NB); Subgroup analysis of updated interim efficacy and safety data for the registrational phase II trial
    Meeting Abstract

    Mora, J.; Bear, M.; Chi-Fung Chan, G.; Morgenstern, D.; Nysom, K.; Tornoe, K.; Losic, N.; Kushner, B.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Real world treatment of pediatric patients with down syndrome and relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-All) treated with tisagenlecleucel
    Meeting Abstract

    Pacenta, H.; Schultz, L.; Baggott, C.; Shah, N.; Prabhu, S.; Phillips, C.; Rossoff, J.; Stefanski, H.; Talano, J. A.; Moskop, A.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Practice patterns for primary site radiotherapy in high-risk neuroblastoma at US proton centers: A report from the Pediatric Proton/Photon Consortium Registry (PPCR)
    Meeting Abstract

    Hill-Kayser, C.; Paulino, A.; Hartsell, W.; Wolden, S.; Indelicato, D.; Mangona, V.; Perentesis, J.; Li, Y.; Perkins, S.; Laack, N.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save